Vagifem (Postmenopausal Vaginal Atrophy)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 8
3 Disease Overview 9
3.1 Etiology and Pathophysiology 9
3.1.1 Etiology 9
3.1.2 Pathophysiology 9
3.1.3 Prognosis 10
3.1.4 Quality of Life 10
3.2 Symptoms 10
4 Disease Management 12
4.1 Treatment Overview 12
4.2 Treatment Guidelines 12
4.3 Disease Management 13
5 Competitive Assessment 16
5.1 Overview 16
5.2 Strategic Competitor Assessment 17
6 Vagifem (estradiol vaginal tablet) 19
6.1 Overview 19
6.2 Efficacy 20
6.3 Safety 20
6.4 SWOT Analysis 21
6.5 Forecast 22
7 Appendix 23
7.1 Bibliography 23
7.2 Abbreviations 26
7.3 Methodology 28
7.4 Forecasting Methodology 28
7.4.1 Diagnosed postmenopausal atrophy patients 28
7.4.2 Percent Drug-Treated Patients 29
7.4.3 Patent Expiry Dates 29
7.4.4 General Pricing Assumptions 29
7.4.5 Individual Drug Assumptions 30
7.4.6 Generic Erosion 30
7.5 Physicians and Specialists Included in This Study 31
7.6 About the Authors 33
7.6.1 Author 33
7.6.2 Epidemiologists 33
7.6.3 Global Director of Epidemiology and Clinical Trials Analysis 34
7.6.4 Director of Oncology, Hematology and Gender Health 34
7.6.5 Global Head of Healthcare 35
7.7 About GlobalData 36
7.8 Disclaimer 36